Learn more about the national shortage of Cisplatin and Carboplatin used to treat cancer, due to several factors including manufacturing delays. and UTMC is mitigating this situation and continuing to prioritize patient care, wellbeing, and safety.
Due to several factors including manufacturing delays, healthcare providers across the United States, including The University of Tennessee Medical Center (UTMC) are facing a shortage of Cisplatin and Carboplatin. Our commitment remains to serving the medical needs of citizens of the East Tennessee region and provide comprehensive and focused care to the patients in our dedicated Cancer Institute.